Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00980044|
Recruitment Status : Completed
First Posted : September 18, 2009
Results First Posted : December 3, 2014
Last Update Posted : April 5, 2017
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Treatment|
Substance Withdrawal Syndrome
|Recruitment Details||Outpatient screening. Recruitment by advertisement and word or mouth.|
Persons screening who did not meet inclusion/ exclusion criteria were not enrolled.
Persons who did not complete the study were not included in analyses. The study was designed as an efficacy study that a priori stated it would enroll until 12 persons in each group completed the study and analyse only completers. No serious AEs in noncompleters.